- Home
- Vascular Interventions Online 2021 - Venous - Part 2
Vascular Interventions Online 2021 - Venous - Part 2
- Intervention
- Vascular
Available Credit:
- 1.00
Course Published On:
Course Expiry Date:
Overview
This session, Venous – Part 2, part of Vascular Interventions Online 2021, features a number of practical demonstrations in the form of live case broadcasts from cardiovascular centers, such as Stony Brook University and Guy’s and St Thomas’ NHS Foundation Trust London.
Vascular Interventions Online (VIO) aims to educate vascular professionals, interventionalists and surgeons who are involved and/or interested in vascular interventional treatment with a focus on Aortic, Venous and PAD / Lower Limb.
Support Statement
This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.
- Bentley
- Shockwave Medical
Disclosure
In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.
The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.
Terms & Conditions
Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
The session of ‘Vascular Interventions Online 2021 - Venous – Part 2’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.
Instructions to Participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 75 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
- Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
- Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Target Audience
- Vascular professionals,
- Interventionalists
- Surgeons who are involved and/or interested in Aortic, Venous, and PAD / Lower Limb
Learning Objectives
The overall programme, Vascular Interventions Online 2021, endeavours to best address the following learning objectives:
- To develop an understanding of available treatment strategies for challenging and difficult access procedures
- To update knowledge on the latest technological developments and options
- To gain insight into tips and tricks employed at leading international centres
Module |
Title |
Duration |
Speakers |
|---|---|---|---|
| Presentation | Treatment of Chronic Disease | Efthymios Avgerinos (University of Pittsburgh Medical Center, Pittsburgh, US) | |
| Live Case | Superficial Vein Reflux Treatment | Antonios Gasparis (Stony Brook University Medical Center, Stony Brook, NY, US) Nicos Labropoulos (Stony Brook University Medical Center, Stony Brook, NY, US) | |
| Presentation | Pelvic Vein Reflux | Emma Wilton (Oxford University Hospitals NHS Foundation Trust, Oxford, UK) |
Treatment of Chronic Disease
Duration:
Speakers: Efthymios Avgerinos (University of Pittsburgh Medical Center, Pittsburgh, US)
Superficial Vein Reflux Treatment
Duration:
Speakers: Antonios Gasparis (Stony Brook University Medical Center, Stony Brook, NY, US) Nicos Labropoulos (Stony Brook University Medical Center, Stony Brook, NY, US)
Pelvic Vein Reflux
Duration:
Speakers: Emma Wilton (Oxford University Hospitals NHS Foundation Trust, Oxford, UK)
Chair
Panelist
Operator
Related Courses
- 0.75
Published:
Learning objectives
- Identify suitable patients for transcatheter repair over other treatments
- Recall long-term clinical outcomes for TEER in patients with DMR
- Select TEER devices based on design features and clinical data
- Review TEER implantation techniques
- 1.00
Published:
Learning objectives
- Recall the critical steps in lesion preparation and on post dilation to optimise valve implantation when needed
- Recognise the technical considerations in precise valve positioning and deployment for larger annuli patients
- Explore the long-term implications of index procedure optimisation on patient management and outcomes
- Engage with an expert operator through a live case demonstration and interactive discussion
- 1.00
Published:
Learning objectives
- Evaluate the factors influencing coronary access in different valve designs
- Formulate strategies to optimise coronary access based on valve characteristics
- Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
- Learn the step-by-step process for achieving optimum implant depth during TAVI
- Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI